These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38790029)

  • 1. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
    Kitade M; Kumakiri J; Kobori H; Murakami K
    Trials; 2024 May; 25(1):343. PubMed ID: 38790029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
    Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
    Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term administration of oral relugolix before single-port laparoscopic-assisted vaginal hysterectomy for symptomatic uterine myomas: A retrospective comparative study with leuprorelin injection.
    Takeda A
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1921-1929. PubMed ID: 35460303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial.
    Kawahara N; Kawaguchi R; Yamamoto K; Nishikawa K; Matsuoka M; Maehana T; Fukui Y; Yamanaka S; Sugimoto S; Iwai K; Yamada Y; Kurakami H; Hirata T; Takashima R; Suzuki S; Asada K; Kasahara M; Kimura F
    Trials; 2024 Jan; 25(1):68. PubMed ID: 38243317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
    Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
    Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
    Zullo F; Venturella R; Raffone A; Saccone G
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
    Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.
    Osuga Y; Enya K; Kudou K; Hoshiai H
    Fertil Steril; 2019 Nov; 112(5):922-929.e2. PubMed ID: 31594635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relugolix for the treatment of uterine fibroids.
    Rocca ML; Palumbo AR; Lico D; Fiorenza A; Bitonti G; D'Agostino S; Gallo C; Di Carlo C; Zullo F; Venturella R
    Expert Opin Pharmacother; 2020 Oct; 21(14):1667-1674. PubMed ID: 32674616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
    Osuga Y; Seki Y; Tanimoto M; Kusumoto T; Kudou K; Terakawa N
    BMC Womens Health; 2021 Jun; 21(1):250. PubMed ID: 34154590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.
    Bhave Chittawar P; Franik S; Pouwer AW; Farquhar C
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004638. PubMed ID: 25331441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
    Hoshiai H; Seki Y; Kusumoto T; Kudou K; Tanimoto M
    BMC Womens Health; 2021 Oct; 21(1):375. PubMed ID: 34711224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HOD; Li Y; McKain L; Arjona Ferreira JC; Langenberg AGM; Wagman RB; Stewart EA
    N Engl J Med; 2021 Feb; 384(7):630-642. PubMed ID: 33596357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    Sangkomkamhang US; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
    de Milliano I; Huirne JAF; Thurkow AL; Radder C; Bongers MY; van Vliet H; van de Lande J; van de Ven PM; Hehenkamp WJK
    Acta Obstet Gynecol Scand; 2020 Jan; 99(1):89-98. PubMed ID: 31468503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.